Biological compatibility and micromorphologic observation of three dimensional porous beta-tricalcium phosphate scaffolds and mesenchymal stem cells in constructing tissue engineered bone

XB Cheng,Q Ma,R Hou,YW Yang,TQ Mao,JH Ao

DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.09.013

2007-01-01

Abstract:Aim: A quantitative and micromorphologic observation of tissue compatibility of three-dimensional porous beta-tricaicium phosphate (β-TCP) scaffold in tissue engineered bone. Methods: From July 2002 to July 2005 the experiment was performed in Tissue Engineering Laboratory, Department of Oral and Maxillofacial Surgery, Stomatological College, Fourth Military Medical University of Chinese PLA. Mesenchymal stem cells (MSCs) of rabbit was placed in the wells of microplate quantitatively, then β-TCP scaffolds were put into the wells for coculture. Activity of MSCs was evaluated by MTT assay and alkaline phosphatase (ALP) kit, and the micromorphology of MSCs was observed on the surface of β-TCP by confocal microscope. Results: The osteoblasts had uniformity appearance under the inverted microscope before inoculation. 2 6 days after inoculation there were many osteoblast and filarious extracellular matrix under the scanning electron microscope. 3 6 days after inoculation, there were large number of osteoblast on the surface and in the pore of the scaffold material under the laser confocal microscopy. 4 Proliferative effect of β-TCP on MSCs: On the 5th day, the proliferative effect (A) of β-TCP on MSCs in the β-TCP group was lower than that in the control group. There were significant differences (0.47±-0.02, 0.52:±0.02, t =2.281, P < 0.05). 5 Activity of alkaline phosphatase in osteoblasts: The activity of alkaline phosphatase (A) in β-TCP group was obviously lower than that in the control group at days 5, 7 and 9. There were significant differences (5.18±0.31, 6.05±0.54; 12.3±0.62, 14.17±0.70; 15.68±0.87, 17.13±1.14, t =3.302, 6.025, 6.019, P < 0.05). Conclusion: Three dimensional porous β-TCP scaffold has favourable tissue compatibility, and these experiments offer a credible experimental evidence to clinical application of β-TCP scaffold.